Annual FCF
-$117.11 M
-$74.04 M-171.94%
December 31, 2024
Summary
- As of March 12, 2025, MLTX annual free cash flow is -$117.11 million, with the most recent change of -$74.04 million (-171.94%) on December 31, 2024.
- MLTX annual FCF is now -171.94% below its all-time high of -$43.06 million, reached on December 31, 2023.
Performance
MLTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$48.65 M
-$23.24 M-91.48%
December 31, 2024
Summary
- As of March 12, 2025, MLTX quarterly free cash flow is -$48.65 million, with the most recent change of -$23.24 million (-91.48%) on December 31, 2024.
- Over the past year, MLTX quarterly FCF has dropped by -$23.24 million (-91.48%).
- MLTX quarterly FCF is now -439.09% below its all-time high of -$9.02 million, reached on March 31, 2023.
Performance
MLTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$117.11 M
-$36.30 M-44.93%
December 31, 2024
Summary
- As of March 12, 2025, MLTX TTM free cash flow is -$117.11 million, with the most recent change of -$36.30 million (-44.93%) on December 31, 2024.
- Over the past year, MLTX TTM FCF has dropped by -$36.30 million (-44.93%).
- MLTX TTM FCF is now -724.58% below its all-time high of -$14.20 million, reached on March 31, 2022.
Performance
MLTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
MLTX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -171.9% | -91.5% | -44.9% |
| 3 y3 years | - | -439.1% | -130.8% |
| 5 y5 years | - | -439.1% | -130.8% |
MLTX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -171.9% | at low | -439.1% | at low | -724.6% | at low |
| 5 y | 5-year | -171.9% | at low | -439.1% | at low | -724.6% | at low |
| alltime | all time | -171.9% | at low | -439.1% | at low | -724.6% | at low |
MoonLake Immunotherapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$117.11 M(+171.9%) | -$48.65 M(+91.5%) | -$117.11 M(+44.9%) |
| Sep 2024 | - | -$25.41 M(-8.9%) | -$80.80 M(+25.0%) |
| Jun 2024 | - | -$27.89 M(+84.0%) | -$64.65 M(+32.2%) |
| Mar 2024 | - | -$15.16 M(+22.8%) | -$48.91 M(+14.3%) |
| Dec 2023 | -$43.06 M | -$12.34 M(+33.4%) | -$42.78 M(+1.8%) |
| Sep 2023 | - | -$9.25 M(-23.9%) | -$42.03 M(-0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$12.16 M(+34.7%) | -$42.13 M(-17.0%) |
| Mar 2023 | - | -$9.02 M(-22.2%) | -$50.73 M(-9.3%) |
| Dec 2022 | -$55.91 M | -$11.60 M(+24.0%) | -$55.91 M(+26.2%) |
| Sep 2022 | - | -$9.35 M(-55.0%) | -$44.31 M(+26.7%) |
| Jun 2022 | - | -$20.76 M(+46.2%) | -$34.96 M(+146.2%) |
| Mar 2022 | - | -$14.20 M | -$14.20 M |
FAQ
- What is MoonLake Immunotherapeutics annual free cash flow?
- What is the all time high annual FCF for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual FCF year-on-year change?
- What is MoonLake Immunotherapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly FCF year-on-year change?
- What is MoonLake Immunotherapeutics TTM free cash flow?
- What is the all time high TTM FCF for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM FCF year-on-year change?
What is MoonLake Immunotherapeutics annual free cash flow?
The current annual FCF of MLTX is -$117.11 M
What is the all time high annual FCF for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual free cash flow is -$43.06 M
What is MoonLake Immunotherapeutics annual FCF year-on-year change?
Over the past year, MLTX annual free cash flow has changed by -$74.04 M (-171.94%)
What is MoonLake Immunotherapeutics quarterly free cash flow?
The current quarterly FCF of MLTX is -$48.65 M
What is the all time high quarterly FCF for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly free cash flow is -$9.02 M
What is MoonLake Immunotherapeutics quarterly FCF year-on-year change?
Over the past year, MLTX quarterly free cash flow has changed by -$23.24 M (-91.48%)
What is MoonLake Immunotherapeutics TTM free cash flow?
The current TTM FCF of MLTX is -$117.11 M
What is the all time high TTM FCF for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM free cash flow is -$14.20 M
What is MoonLake Immunotherapeutics TTM FCF year-on-year change?
Over the past year, MLTX TTM free cash flow has changed by -$36.30 M (-44.93%)